|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.6608 USD | -9.60% |
|
+4.00% | -78.19% |
| 10-07 | Lantern Pharma Inc. Receives Taiwan Approvals to Open Next Stage of Phase 2 Harmonic Trial of Lp-300 in Never-Smoker, Egfr-Mutant Nsclc | CI |
| 09-23 | Lantern Pharma Inc. - Special Call |
| Market Cap | 8.45M 7.57M 6.96M 6.31M 11.79M 802M 12.01M 82.99M 33.32M 422M 31.7M 31.03M 1.33B | P/E 2026 * |
-0.41x | P/E 2027 * | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 8.45M 7.57M 6.96M 6.31M 11.79M 802M 12.01M 82.99M 33.32M 422M 31.7M 31.03M 1.33B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
82.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LTRN | Delayed | |
CBOE
| LTRN | Real-time |
Last Transcript: Lantern Pharma Inc.
| 1 day | -9.60% | ||
| 1 week | +4.00% | ||
| Current month | -34.57% | ||
| 1 month | -34.57% | ||
| 3 months | -75.06% | ||
| 6 months | -67.77% | ||
| Current year | -78.19% |
| 1 week | 0.6 |  | 0.84 |
| 1 month | 0.59 | | 1.07 |
| Current year | 0.59 | | 4.34 |
| 1 year | 0.59 | | 4.34 |
| 3 years | 0.59 | | 11.99 |
| 5 years | 0.59 | | 11.99 |
| 10 years | 0.59 | | 24.84 |
| Manager | Title | Age | Since |
|---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 55 | 2018-06-30 |
David Margrave
DFI | Director of Finance/CFO | 66 | 2019-10-31 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 2023-03-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Donald Keyser
CHM | Chairman | 73 | 2019-10-31 |
Panna Sharma
BRD | Director/Board Member | 55 | 2018-06-30 |
| Director/Board Member | 75 | 2018-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/12/26 | Buy | Chairman | 97,088 | 0.8662% | ||
| 5/12/26 | Buy | Director | 97,088 | 0.8662% | ||
| 1/9/26 | Free | Director | 43,460 | 0.3886% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.60% | +4.00% | -83.36% | -74.58% | 8.45M | |
| -0.62% | -1.87% | +46.31% | +56.99% | 63.77B | |
| +0.35% | +3.20% | +14.92% | +84.55% | 56.37B | |
| +0.53% | +1.96% | +15.37% | +106.81% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +50.90% | 44.06B | |
| -0.33% | -1.93% | +20.15% | +98.45% | 42.11B | |
| +0.55% | +2.31% | +224.97% | +942.56% | 41B | |
| +3.27% | +47.96% | +112.67% | +96.48% | 34.92B | |
| +1.22% | -1.44% | +14.89% | +47.15% | 32.82B | |
| +0.89% | +20.55% | -42.03% | +373.03% | 24.7B | |
| Average | -0.66% | +7.19% | +34.74% | +178.23% | 39.44B | |
| Weighted average by Cap. | +0.18% | +5.44% | +48.50% | +186.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -19.91M -17.83M -16.4M -14.86M -27.77M -1.89B -28.29M -196M -78.5M -994M -74.71M -73.12M -3.14B | -22.75M -20.37M -18.74M -16.98M -31.74M -2.16B -32.34M -223M -89.72M -1.14B -85.38M -83.56M -3.58B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$0.6608 | -9.60% | 218,533 |
| 26-10-29 | US$0.7310 | -5.52% | 233,907 |
| 26-10-28 | US$0.7737 | +20.89% | 603,764 |
| 26-10-27 | US$0.6400 | +2.60% | 72,394 |
| 26-10-26 | US$0.6238 | -1.83% | 116,128 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LTRN Stock
Select your edition
All financial news and data tailored to specific country editions
